Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-17T19:08:21.349Z Has data issue: false hasContentIssue false
  • English
  • Français

Treatment modality: a predictor of continued tobacco use after treatment in patients with laryngeal cancer

Published online by Cambridge University Press:  28 January 2014

V Narwani  and
M Harries
V Narwani*
Affiliation:
Brighton and Sussex Medical School, Brighton, UK
M Harries
Affiliation:
ENT Department, Royal Sussex County Hospital, Brighton, UK
*
Address for correspondence: Mr V Narwani, Brighton and Sussex Medical School, Audrey Emerton Building, Eastern Road, Brighton, BN2 5BE, United Kingdom E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Laryngeal cancer patients who continue to smoke after treatment are at an elevated risk of mortality and morbidity. This study aimed to identify factors associated with continued tobacco use following treatment in patients with laryngeal cancer.

Methods:

A smoking behaviour questionnaire, a self-report measure, was sent to 112 patients who were diagnosed with laryngeal cancer during 2006–2011 at the Brighton and Sussex University Hospitals, Brighton, UK. Patient demographics, tumour and treatment-related variables, comorbidity and socio-economic status were obtained from the medical records.

Results:

Eighty-one per cent of patients responded to the survey; 22 per cent of these reported continued tobacco use after treatment. Treatment modality was found to be a predictor of post-therapeutic smoking (odds ratio: 4.9, p = 0.01); patients who received less invasive therapy (transoral laser microsurgery) were more likely to smoke after treatment.

Conclusions:

The findings of this preliminary study suggest that treatment modality influences smoking behaviour in patients with laryngeal cancer, which may have important implications for the design of anti-smoking interventions.

Keywords

Laryngeal NeoplasmsSmokingCompliancePreventive Measures
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 128 , Issue 2 , February 2014 , pp. 153 - 158
Copyright
Copyright © JLO (1984) Limited 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Parkin, DM, Bray, F, Ferlay, J, Pisani, P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108Google Scholar
2Rachet, B, Quinn, MJ, Cooper, N, Coleman, MP. Survival from cancer of the larynx in England and Wales up to 2001. Br J Cancer 2008;99(suppl 1):35–7Google Scholar
3Allison, PJ. Factors associated with smoking and alcohol consumption following treatment for head and neck cancer. Oral Oncol 2001;37:513–20Google Scholar
4Thun, MJ, DeLancey, JO, Center, MM, Jemal, A, Ward, EM. The global burden of cancer: priorities for prevention. Carcinogenesis 2010;31:100–10CrossRefGoogle ScholarPubMed
5Hashibe, M, Brennan, P, Chuang, SC, Boccia, S, Castellsague, X, Chen, C et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009;18:541–50Google Scholar
6Ostroff, JS, Jacobsen, PB, Moadel, AB, Spiro, RH, Shah, JP, Strong, EW et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 1995;75:569–76Google Scholar
7Moore, C. Cigarette smoking and cancer of the mouth, pharynx, and larynx. A continuing study. JAMA 1971;218:553–8CrossRefGoogle ScholarPubMed
8Gritz, ER, Carr, CR, Rapkin, D, Abemayor, E, Chang, LJ, Wong, WK et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993;2:261–70Google ScholarPubMed
9Schnoll, RA, Rothman, RL, Newman, H, Lerman, C, Miller, SM, Movsas, B et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology 2004;13:346–58Google Scholar
10De Boer, MF, Van den Borne, B, Pruyn, JF, Ryckman, RM, Volovics, L, Knegt, PP et al. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study. Cancer 1998;83:2567–793.0.CO;2-X>CrossRefGoogle ScholarPubMed
11Browman, GP, Wong, G, Hodson, I, Sathya, J, Russell, R, McAlpine, L et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993;328:159–63Google Scholar
12León, X, del Prado Venegas, M, Orús, C, López, M, García, J, Quer, M. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer. A case-control study. Cancer Causes Control 2009;20:645–52Google Scholar
13Chen, AM, Chen, LM, Vaughan, A, Sreeraman, R, Farwell, DG, Luu, Q et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys 2011;79:414–19CrossRefGoogle ScholarPubMed
14Bradley, PJ, Mackenzie, K, Wight, R, Pracy, P, Paleri, V. Consensus statement on management in the UK: transoral laser assisted microsurgical resection of early glottic cancer. Clin Otolaryngol 2009;34:367–73Google Scholar
15Gritz, ER, Schacherer, C, Koehly, L, Nielsen, IR, Abemayor, E. Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 1999;21:420–73.0.CO;2-U>CrossRefGoogle ScholarPubMed
16Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83Google Scholar
17Townsend, P, Phillimore, P, Beattie, A. Health and Deprivation: Inequality and the North. London, New York: Croom Helm, 1988Google Scholar
18Office for National Statistics. 2011 Census. Who we are. How we live. What we do. In: www.ons.gov.uk/ons/guide-method/census/2011/index.html [11 December 2013]Google Scholar
19Muscat, JE, Liu, HP, Livelsberger, C, Richie, JP Jr, Stellman, SD. The nicotine dependence phenotype, time to first cigarette, and larynx cancer risk. Cancer Causes Control 2012;23:497–503Google Scholar
20Schnoll, RA, Malstrom, M, James, C, Rothman, RL, Miller, SM, Ridge, JA et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns 2002;46:137–45CrossRefGoogle ScholarPubMed
21Núñez Batalla, F, Caminero Cueva, MJ, Señaris González, B, Llorente Pendás, JL, Gorriz Gil, C, López Llames, A et al. Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index. Eur Arch Otorhinolaryngol 2008;265:543–8Google Scholar
22Loughran, S, Calder, N, MacGregor, FB, Carding, P, MacKenzie, K. Quality of life and voice following endoscopic resection or radiotherapy for early glottic cancer. Clin Otolaryngol 2005;30:42–7CrossRefGoogle ScholarPubMed
23Warren, GW, Arnold, SM, Valentino, JP, Gal, TJ, Hyland, AJ, Singh, AK et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol 2012;103:45–8Google Scholar
24Kvalvik, LG, Nilsen, RM, Skjærven, R, Vollset, SE, Midttun, O, Ueland, PM et al. Self-reported smoking status and plasma cotinine concentrations among pregnant women in the Norwegian Mother and Child Cohort Study. Pediatr Res 2012;72:101–7Google Scholar
25Wells, AJ, English, PB, Posner, SF, Wagenknecht, LE, Perez-Stable, EJ. Misclassification rates for current smokers misclassified as nonsmokers. Am J Public Health 1998;88:1503–9Google Scholar